Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TAK-906 for symptomatic gastroparesis (diabetic and idiopathic) has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Gastroparesis
• Idiopathic Gastroparesis

Drugs mentioned

• TAK-906

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Diabetic Gastroparesis, Idiopathic Gastroparesis | Phase 2 | Status: COMPLETED | Results posted: 2022-11-16